Epidural analgesia in pregnant with deficit of factor VII.
Analgesia epidural en gestante con déficit del factor VII.
Activated recombinant FVII
Déficit congénito FVII
Embarazo
Epidural analgesia
FVII déficit
FVII recombinante activado
Hematoma peridural
Pregnancy
Spinal hematoma
Técnica neuroaxial
Journal
Revista espanola de anestesiologia y reanimacion
ISSN: 2341-1929
Titre abrégé: Rev Esp Anestesiol Reanim (Engl Ed)
Pays: Spain
ID NLM: 101778594
Informations de publication
Date de publication:
13 Mar 2021
13 Mar 2021
Historique:
received:
17
02
2020
revised:
05
12
2020
accepted:
27
12
2020
entrez:
17
3
2021
pubmed:
18
3
2021
medline:
18
3
2021
Statut:
aheadofprint
Résumé
The congenital deficit of FVII of coagulation it's an anomaly of genetic transmission autosomal recessive type, it can occur with clinical manifestations like hematomas and spontaneous bleeding or not. The normal levels of FVII it's found between 70%-130% of the laboratory reference value. For unknown reasons there is a poor correlation between levels of FVII and bleeding risk. During pregnancy coagulation can be significantly altered, there is a no clear consensus and a very few information about how to act during labor in a patient with a FVII deficit. The case of a 35-year-old patient with 35 weeks of gestation and congenital deficit of the coagulation FVII (36%) is presented, epidural analgesia is performed during labor previously administering activated recombinant FVII (rFVIIa) without complications (Spinal hematoma, postpartum bleeding, thrombosis).
Identifiants
pubmed: 33726919
pii: S0034-9356(21)00054-2
doi: 10.1016/j.redar.2020.12.010
pii:
doi:
Types de publication
Case Reports
Langues
eng
spa
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.